ES2094725T3 - Peptidos hcg para la aplicacion en procedimientos de purificacion de anticuerpos. - Google Patents

Peptidos hcg para la aplicacion en procedimientos de purificacion de anticuerpos.

Info

Publication number
ES2094725T3
ES2094725T3 ES89113196T ES89113196T ES2094725T3 ES 2094725 T3 ES2094725 T3 ES 2094725T3 ES 89113196 T ES89113196 T ES 89113196T ES 89113196 T ES89113196 T ES 89113196T ES 2094725 T3 ES2094725 T3 ES 2094725T3
Authority
ES
Spain
Prior art keywords
antibody purification
hcg
application
purification procedures
hcg peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89113196T
Other languages
English (en)
Inventor
Virender K Sarin
John B Bodner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of ES2094725T3 publication Critical patent/ES2094725T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C07K17/06—Peptides being immobilised on, or in, an organic carrier attached to the carrier via a bridging agent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/824—Immunological separation techniques

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

UN METODO DE PURIFICACION DE ANTICUERPOS CON COLUMNAS DE AFINIDAD USANDO UN ANALOGO ANALITICO DEL HCG SINTETICO INSOLUBILIZADO EN UN MATERIAL SOPORTE. LOS ANALOGOS ANALITICOS DEL HCG INMOVILIZADOS SON SECUENCIAS DE PEPTIDOS QUE DUPLICAN O IMITAN LOS DETERMINANTES FORMADOS POR LOS RESIDUOS DE AMINOACIDOS DE LA SECUENCIA PEPTIDA DE TERMINO C O PARTES O VARIACIONES DEL MISMO. LOS ANTICUERPOS PRODUCIDOS DE ACUERDO CON EL PRESENTE INVENTO SON UTILES EN INMUNOTRATAMIENTO DE HCG.
ES89113196T 1988-07-20 1989-07-19 Peptidos hcg para la aplicacion en procedimientos de purificacion de anticuerpos. Expired - Lifetime ES2094725T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22168788A 1988-07-20 1988-07-20
US37573189A 1989-07-10 1989-07-10

Publications (1)

Publication Number Publication Date
ES2094725T3 true ES2094725T3 (es) 1997-02-01

Family

ID=26916030

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89113196T Expired - Lifetime ES2094725T3 (es) 1988-07-20 1989-07-19 Peptidos hcg para la aplicacion en procedimientos de purificacion de anticuerpos.

Country Status (9)

Country Link
US (1) US5451527A (es)
EP (1) EP0351804B1 (es)
JP (2) JP3055063B2 (es)
KR (1) KR910003092A (es)
AT (1) ATE143669T1 (es)
AU (1) AU634479B2 (es)
CA (1) CA1341014C (es)
DE (1) DE68927283T2 (es)
ES (1) ES2094725T3 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE40835E1 (en) * 1992-01-16 2009-07-07 BioGenx Laboratories, Inc. Enhancement of immunochemical staining in aldehyde-fixed tissue
US5968513A (en) * 1996-06-24 1999-10-19 University Of Maryland Biotechnology Institute Method of promoting hematopoiesis using derivatives of human chorionic gonadotropin
US6319504B1 (en) 1996-06-24 2001-11-20 University Of Maryland Biotechnology Institute Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
US5997871A (en) * 1996-06-24 1999-12-07 University Of Maryland Biotechnology Insitute Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin
US6583109B1 (en) 1997-06-24 2003-06-24 Robert C. Gallo Therapeutic polypeptides from β-hCG and derivatives
US7994278B1 (en) 1999-08-06 2011-08-09 Nobel Biosciences Llc Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
WO2012129519A1 (en) * 2011-03-23 2012-09-27 Deseret Biologicals, Inc. Formulations of diluted amino acid segments and methods for making same
US9573987B2 (en) * 2011-12-20 2017-02-21 Indiana University Research And Technology Corporation CTP-based insulin analogs for treatment of diabetes
EP4058810A4 (en) * 2019-11-15 2023-12-20 President And Fellows Of Harvard College DEVICE AND METHOD FOR ANALYTE DETECTION
CN119462922B (zh) * 2023-08-09 2025-11-18 东莞市朋志生物科技有限公司 一种抗人绒毛膜促性腺激素的抗体及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4313871A (en) * 1978-02-06 1982-02-02 Research Corporation Antigen for early pregnancy test and contraceptive vaccine
JPS576363A (en) * 1980-06-13 1982-01-13 Takeda Chem Ind Ltd Production of specific antibody
EP0111216A3 (en) * 1980-03-31 1985-01-16 Takeda Chemical Industries, Ltd. Method for enzyme immunoassay and peptide-enzyme conjugate, its lyophilizate, antibody and kit therefor
DK159276C (da) * 1980-03-31 1991-02-18 Takeda Chemical Industries Ltd Fremgangsmaade til isolering af specifikke antistoffer og enzym-immunbestemmelsesmetode med anvendelse af det isolerede antistof
DE3174064D1 (en) * 1980-10-15 1986-04-17 Takeda Chemical Industries Ltd Method for immunochemical assay and kit therefor
JPS5781447A (en) * 1980-11-11 1982-05-21 Toyo Jozo Co Ltd Human chorionic gonadotropic hormone c-terminal fragment
US4565687A (en) * 1981-11-16 1986-01-21 The Reagents Of The University Of Michigan Monoclonal antibodies specific for the unbound β subunit of human chorionic gonadotropin
ATE42317T1 (de) * 1983-07-29 1989-05-15 Henning Berlin Gmbh Voraktivierte kunststoffoberflaechen zur immobilisierung von organisch-chemischen und biologischen materialien, verfahren zur herstellung und verwendung derselben.
US4804626A (en) * 1986-10-22 1989-02-14 The General Hospital Corporation Immunometric assay for the detection of human chorionic gonadotropin

Also Published As

Publication number Publication date
ATE143669T1 (de) 1996-10-15
JPH02111792A (ja) 1990-04-24
EP0351804B1 (en) 1996-10-02
JP3055063B2 (ja) 2000-06-19
DE68927283D1 (de) 1996-11-07
JP2000159800A (ja) 2000-06-13
AU634479B2 (en) 1993-02-25
JP3174041B2 (ja) 2001-06-11
US5451527A (en) 1995-09-19
KR910003092A (ko) 1991-02-26
DE68927283T2 (de) 1997-04-24
EP0351804A3 (en) 1990-08-01
CA1341014C (en) 2000-06-06
AU3825389A (en) 1990-01-25
EP0351804A2 (en) 1990-01-24

Similar Documents

Publication Publication Date Title
ES2075196T3 (es) Metodo para el uso y la sintesis de peptidos.
DK532284A (da) Fremgangsmaade til bestemmelse af antigenaktive aminosyresekvenser
ATE88572T1 (de) Antikoerper gegen polypeptide, die gegen peptide oder proteine mit mindestens teilweise bekannter aminosaeure oder kodierender nukleotidsequenz komplementaer sind und diesbezuegliches aufbauverfahren.
ES2087323T3 (es) Metodo para producir peptidos exentos de cisteina.
ATE105867T1 (de) Immunaffinitäts-reinigungssystem.
ATE440868T1 (de) Monoklonaler antikírper gegen ein prion protein und dessen verwendung zum nachweis von prionen
ES2177632T3 (es) Purificacion de anticuerpos.
ATE142645T1 (de) Rezeptoren für wachstumshormone
ES2094725T3 (es) Peptidos hcg para la aplicacion en procedimientos de purificacion de anticuerpos.
BR9106220A (pt) Antigenos sinteticos para a deterccao de anticorpos para o virus da hepatite c.
ES2194017T3 (es) Proceso para producir polipeptidos, proteinas o peptidos hidrofobos.
DE60041345D1 (de) Verfahren zur reinigung von an mehreren epitopen fusionierten rekombinanten proteinen
DE68928704D1 (de) Gruppe von getrennten peptiden
ES2109225T3 (es) Anticuerpos, su produccion y uso.
ATE133993T1 (de) Protein-antikrebsmittel
DE69025023D1 (de) Peptide und deren Benutzung
ES2158235T3 (es) Peptidos antigenicos con substituciones de glicina.
NO904129L (no) Antistoffer mot hoeykonserverte aminosyresekvenser fra immunogene forbindelser, fremgangsmaate for fremstilling av antistoffer samt anvendelse derav i immunoanalyser.
DK0485525T3 (da) Monoklonalt antistof mod acetylerede lysinrester i rekombinant bovint somatotropin
Sarin et al. HCG peptides for use in antibody purification procedures
ATE193021T1 (de) Lipoprotein (a)-peptide und deren verwendung

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 351804

Country of ref document: ES